Class information for:
Level 1: ENDOGLIN//CD105//TRC105

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
14371 774 46.9 91%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
27 3       DEVELOPMENTAL BIOLOGY//DEVELOPMENT//AGR2 109777
1072 2             TGF BETA//SMAD//ENDOGLIN 9938
14371 1                   ENDOGLIN//CD105//TRC105 774

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ENDOGLIN authKW 4053302 27% 50% 206
2 CD105 authKW 1589918 12% 44% 92
3 TRC105 authKW 473400 2% 100% 12
4 ALK1 authKW 454802 4% 41% 28
5 CD105 ENDOGLIN authKW 256412 2% 50% 13
6 ACTIVIN RECEPTOR LIKE KINASE 1 authKW 229884 2% 45% 13
7 RENAL CARDIOVASC UNIT address 202884 1% 86% 6
8 ENDOGLIN CD105 authKW 199708 1% 56% 9
9 ANTI ENDOGLIN ANTIBODY authKW 197250 1% 100% 5
10 SOLUBLE CD105 authKW 197250 1% 100% 5

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 1719 26% 0% 198
2 Cell Biology 640 16% 0% 126
3 Peripheral Vascular Diseases 595 9% 0% 68
4 Pathology 314 6% 0% 49
5 Developmental Biology 293 4% 0% 33
6 Hematology 223 6% 0% 46
7 Biochemistry & Molecular Biology 200 17% 0% 135
8 Medicine, Research & Experimental 107 6% 0% 43
9 Cardiac & Cardiovascular System 96 6% 0% 44
10 Genetics & Heredity 45 5% 0% 36

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 RENAL CARDIOVASC UNIT 202884 1% 86% 6
2 REINA SOFIA INVEST NEFROL 158694 4% 14% 29
3 CANC BIOL SURG 118350 0% 100% 3
4 RENAL CARDIOVASC PHYSIOPATHOL UNIT 109579 1% 56% 5
5 UNIDAD FISIOPATOL RENAL CARDIOVASC 86350 1% 24% 9
6 QUEEN SOPHIE RENAL IRSIN 78900 0% 100% 2
7 HEART STROKE LEWAR EXCELLENCE 71008 0% 60% 3
8 INVEST BIOL 63042 10% 2% 78
9 HAINAN PROVINCIAL TROP MED 52599 0% 67% 2
10 HEART STROKE FDN RICHARD LEWAR EXCELLENCE 52599 0% 67% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES A, LIFE SCIENCES 5371 1% 2% 7
2 FRONTIERS IN GENETICS 1766 1% 1% 6
3 ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY 1290 1% 0% 7
4 DIAGNOSTIC IMAGING 1077 0% 1% 2
5 INTERNATIONAL JOURNAL OF CANCER 914 3% 0% 22
6 ANGIOGENESIS 856 0% 2% 1
7 CLINICAL CANCER RESEARCH 833 2% 0% 18
8 VIRCHOWS ARCHIV 574 1% 0% 7
9 CYTOKINE & GROWTH FACTOR REVIEWS 438 0% 0% 3
10 CANCER CELLS-A MONTHLY REVIEW 409 0% 1% 1

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 ENDOGLIN 4053302 27% 50% 206 Search ENDOGLIN Search ENDOGLIN
2 CD105 1589918 12% 44% 92 Search CD105 Search CD105
3 TRC105 473400 2% 100% 12 Search TRC105 Search TRC105
4 ALK1 454802 4% 41% 28 Search ALK1 Search ALK1
5 CD105 ENDOGLIN 256412 2% 50% 13 Search CD105+ENDOGLIN Search CD105+ENDOGLIN
6 ACTIVIN RECEPTOR LIKE KINASE 1 229884 2% 45% 13 Search ACTIVIN+RECEPTOR+LIKE+KINASE+1 Search ACTIVIN+RECEPTOR+LIKE+KINASE+1
7 ENDOGLIN CD105 199708 1% 56% 9 Search ENDOGLIN+CD105 Search ENDOGLIN+CD105
8 ANTI ENDOGLIN ANTIBODY 197250 1% 100% 5 Search ANTI+ENDOGLIN+ANTIBODY Search ANTI+ENDOGLIN+ANTIBODY
9 SOLUBLE CD105 197250 1% 100% 5 Search SOLUBLE+CD105 Search SOLUBLE+CD105
10 ALK1 ACVRL1 157800 1% 100% 4 Search ALK1+ACVRL1 Search ALK1+ACVRL1

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 FONSATTI, E , NICOLAY, HJM , ALTOMONTE, M , COVRE, A , MAIO, M , (2010) TARGETING CANCER VASCULATURE VIA ENDOGLIN/CD105: A NOVEL ANTIBODY-BASED DIAGNOSTIC AND THERAPEUTIC STRATEGY IN SOLID TUMOURS.CARDIOVASCULAR RESEARCH. VOL. 86. ISSUE 1. P. 12 -19 81 84% 86
2 PAAUWE, M , TEN DIJKE, P , HAWINKELS, LJAC , (2013) ENDOGLIN FOR TUMOR IMAGING AND TARGETED CANCER THERAPY.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 17. ISSUE 4. P. 421 -435 104 69% 13
3 LOPEZ-NOVOA, JM , BERNABEU, C , (2010) THE PHYSIOLOGICAL ROLE OF ENDOGLIN IN THE CARDIOVASCULAR SYSTEM.AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. VOL. 299. ISSUE 4. P. H959 -H974 103 61% 48
4 BERNABEU, C , LOPEZ-NOVOA, JM , QUINTANILLA, M , (2009) THE EMERGING ROLE OF TGF-BETA SUPERFAMILY CORECEPTORS IN CANCER.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. VOL. 1792. ISSUE 10. P. 954 -973 123 46% 103
5 NASSIRI, F , CUSIMANO, MD , SCHEITHAUER, BW , ROTONDO, F , FAZIO, A , YOUSEF, GM , SYRO, LV , KOVACS, K , LLOYD, RV , (2011) ENDOGLIN (CD105): A REVIEW OF ITS ROLE IN ANGIOGENESIS AND TUMOR DIAGNOSIS, PROGRESSION AND THERAPY.ANTICANCER RESEARCH. VOL. 31. ISSUE 6. P. 2283-2290 71 72% 75
6 DALLAS, NA , SAMUEL, S , XIA, L , FAN, F , GRAY, MJ , LIM, SJ , ELLIS, LM , (2008) ENDOGLIN (CD105): A MARKER OF TUMOR VASCULATURE AND POTENTIAL TARGET FOR THERAPY.CLINICAL CANCER RESEARCH. VOL. 14. ISSUE 7. P. 1931-1937 55 89% 158
7 SEON, BK , HABA, A , MATSUNO, F , TAKAHASHI, N , TSUJIE, M , SHE, XW , HARADA, N , UNEDA, S , TSUJIE, T , TOI, H , ET AL (2011) ENDOGLIN-TARGETED CANCER THERAPY.CURRENT DRUG DELIVERY. VOL. 8. ISSUE 1. P. 135-143 54 82% 63
8 TEN DIJKE, P , GOUMANS, MJ , PARDALI, E , (2008) ENDOGLIN IN ANGIOGENESIS AND VASCULAR DISEASES.ANGIOGENESIS. VOL. 11. ISSUE 1. P. 79-89 72 61% 133
9 FONSATTI, E , ALTOMONTE, M , NICOTRA, MR , NATALI, PG , MAIO, M , (2003) ENDOGLIN (CD105): A POWERFUL THERAPEUTIC TARGET ON TUMOR-ASSOCIATED ANGIOGENETIC BLOOD VESSELS.ONCOGENE. VOL. 22. ISSUE 42. P. 6557-6563 62 75% 151
10 MAHMOUD, M , UPTON, PD , ARTHUR, HM , (2011) ANGIOGENESIS REGULATION BY TGF BETA SIGNALLING: CLUES FROM AN INHERITED VASCULAR DISEASE.BIOCHEMICAL SOCIETY TRANSACTIONS. VOL. 39. ISSUE . P. 1659-1666 54 78% 20

Classes with closest relation at Level 1


Rank Class id link
1 5947 HEREDITARY HEMORRHAGIC TELANGIECTASIA//PULMONARY ARTERIOVENOUS MALFORMATION//HEREDITARY HAEMORRHAGIC TELANGIECTASIA
2 29076 MIIP//BETAGLYCAN//T BETA RIII
3 6121 MICROVESSEL DENSITY//ANGIOGENESIS//MICROVESSEL COUNT
4 24524 ADVENTITIAL FIBROBLASTS//CAROTID ARTERY RESTENOSIS//ADVENTITIA
5 12726 BONE MORPHOGENETIC PROTEIN 9//BMP9//BONE MORPHOGENETIC PROTEIN
6 11708 DLL4//VASC PATTERNING//DELTA LIKE LIGAND 4
7 26911 ENDOSIALIN//CD248//ENDOTHELIAL LIKE DIFFERENTIATION
8 31678 ENDMT//ENDOTHELIAL MESENCHYMAL TRANSITION//ENDOTHELIAL TO MESENCHYMAL TRANSITION
9 1117 SMAD//SMAD4//TGF BETA
10 1881 TGF BETA RECEPTORS//TRANSFORMING GROWTH FACTOR BETA//TGF BETA

Go to start page